El equipo de Resonancia Magnética del Grup Clínica Girona no solo trabaja con QP-Prostate: la herramienta ha sido validada en la práctica clínica para la detección del cáncer de próstata clínicamente significativo en la práctica diaria. Investigación que se convierte en evidencia. Gracias por vuestro compromiso con la innovación. ¡Enhorabuena por el reconocimiento Quibim Luminaries! #SaludMasculina #CancerDeProstata #IA
We will be attending the 2nd Annual Global AI Conference 2026, organized by The Royal College of Radiologists at the QEII Centre, June 29–30. Stop by to see how we’re turning medical images into useful biomarkers using AI. 👉 You’ll find us at booth 24: book a time slot for a meeting before the schedule fills up https://bit.ly/3QPkDCq Francesca Evans | Javier Pizcueta Pastor | Emmanuel L. #RCR2026 #AIinHealthcare #Radiology #ImagingBiomarkers
Hemos sido reconocidas entre las primeras compañías españolas que lideran la Inteligencia Artificial, según la iniciativa The Next 35 impulsada por PATIO Campus. Este reconocimiento nos sitúa en el top 10 de empresas que están transformando sectores clave mediante la aplicación responsable y escalable de la IA. En Quibim trabajamos para mejorar la vida de las personas a través de la imagen médica y la inteligencia artificial, acelerando el diagnóstico y la investigación biomédica. Agradecemos a Patio Campus y a las entidades colaboradoras por promover este espacio de crecimiento y colaboración. Seguimos avanzando para que la tecnología se conecte con la salud. #TheNext35 #ArtificialIntelligence #HealthTech #Innovation #AIforHealth #PatioCampus
Imaging is the most underused data in drug development. We're changing that. Quibim's AI turns medical images into quantitative biomarkers, powering better patient stratification, treatment monitoring, and clinical decisions across the development lifecycle. The future of precision medicine is multimodal. Let's build it together. Find us at #BIO2026. Ángel Alberich-Bayarri | Itta MacNevin Biotechnology Innovation Organization #AIinHealthcare #ImagingBiomarkers #PrecisionMedicine #DrugDevelopment
In honor of #WorldProstateCancerDay, we’re sharing this reflection by Santiago Gomez Diaz, first vice president of ANCAP. Asociación de Cáncer de Próstata, published on iSanidad. His message is clear: early detection changes the prognosis. It is a call to continue improving early detection, move toward more accurate and equitable diagnostic models, and remember that innovation, including #AI applied to medical imaging, can be a powerful ally in anticipating the disease and reducing inequalities in access to diagnosis. 📰 https://lnkd.in/dVBqiy2u #ProstateCancer #EarlyDetection #AI #MedicalImaging
Uncertainty is not a side effect of prostate cancer diagnosis. It's a problem we chose to solve. Today, we're proud to announce that QP-Prostate® v2.4 received the Health Canada Licence. 🇨🇦 Canadian physicians now have access to an AI-powered prostate MRI analysis designed to provide clarity, confidence, and better answers for patients. 📰 https://bit.ly/4xjW2Gp #ProstateCancer #AI #MedicalTechnology #QPProstate
We were delighted to welcome the participants of the 1st ESUR Junior Network Summer School, taking place in Valencia from June 9–12, to our headquarters and give them a firsthand look at our work in the field of AI-based imaging biomarkers. As part of the programme, attendees joined us for a Quibim Experience — an immersive session giving them direct access to our technology and the team behind it. What made the day truly special was the energy in the room. The questions, discussions, and genuine enthusiasm of all attendees turned the session into a genuine dialogue, exactly the kind of exchange that drives this field forward. #ESUR #ProstateMRI #MedicalImaging #Radiology
Manually verifying RBAC on clinical imaging platforms used to take our team two full business days for each release cycle. We created a configuration-based, automatically generated testing architecture that reduced that time to 45 minutes. Same coverage. Zero manual effort required. In our latest blog post, Ernest Marzá Climent explains exactly how we did it: runtime permission resolution, dynamic test generation, and a dual-state assertion model that handles the nuances of regulated software 👉 https://bit.ly/4g6X6Hi #TestAutomation #RBAC g#MedicalDeviceSoftware #HealthTech #MedicalImaging
QP-Prostate® 3.0* is here. Transition zone assessment has long been one of radiology's most complex challenges. QP-Prostate® v3.0 changes that today. 🔸 Improved transition zone detection, so radiologists spend less time on noise and more on what matters. 🔸 Enhanced 1.5T scanner performance – because not every site runs on a 3T. 🔸 Validated across global sites – precision that doesn’t depend on geography. At Quibim, we don't just create new versions of our AI models. We raise the bar for what AI-powered radiology can do. #Radiology #AIinHealthcare g#MedicalImaging #ProstateMRI #Quibim #HealthcareInnovation *𝘕𝘰𝘵 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘪𝘯 𝘢𝘭𝘭 𝘤𝘰𝘶𝘯𝘵𝘳𝘪𝘦𝘴. 𝘊𝘰𝘯𝘵𝘢𝘤𝘵 𝘘𝘶𝘪𝘣𝘪𝘮 𝘧𝘰𝘳 𝘮𝘰𝘳𝘦 𝘥𝘦𝘵𝘢𝘪𝘭𝘴.
That's a wrap on the American Society of Clinical Oncology (ASCO) Annual Meeting! Thank you to everyone who visited Quibim's booth and shared inspiring conversations about the future of AI-driven imaging research. One thing was clear throughout the event: imaging data holds untapped potential. Do you want to continue the conversation about how QP-Insights® helps research teams transform image repositories into scalable, reproducible insights using AI-driven radiomics and standardized workflows? Contact us: https://bit.ly/3RD7UTF See you next year! #ASCO26 #MedicalImaging #AIinHealth #PrecisionMedicine #Oncology
